TABLE 1.
Sample group | GP5+/6+-PCR result | No. (%) with indicated result by SPF10 assay
|
Total (%) | P valuea | |
---|---|---|---|---|---|
Negative | Positive | ||||
Overall | |||||
Controls | Negative | 163 (62) | 72 (27) | 235 (89) | <0.001 |
Positive | 6 (2) | 23 (9) | 29 (11) | ||
Total | 169 (64) | 95 (36) | 264 | ||
Cases | Negative | 4 (9) | 1 (2) | 5 (11) | 1.0 |
Positive | 1 (2) | 39 (87) | 40 (89) | ||
Total | 5 (11) | 40 (89) | 45 | ||
Screening cohort | |||||
Controls | Negative | 127 (66) | 53 (27) | 180 (93) | <0.001 |
Positive | 4 (2) | 9 (5) | 13 (7) | ||
Total | 131 (68) | 62 (32) | 193 | ||
Cases | Negative | 2 (8) | 1 (4) | 3 (12) | 1.0 |
Positive | 1 (4) | 21 (84) | 22 (88) | ||
Total | 3 (12) | 22 (88) | 25 | ||
Hospital cohort | |||||
Controls | Negative | 36 (51) | 19 (27) | 55 (77) | <0.001 |
Positive | 2 (3) | 14 (20) | 16 (23) | ||
Total | 38 (54) | 33 (46) | 71 | ||
Cases | Negative | 2 (10) | 0 | 2 (10) | 1.0 |
Positive | 0 | 18 (90) | 18 (90) | ||
Total | 2 (10) | 18 (90) | 20 |
McNemar.